These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21757127)

  • 1. A critical reappraisal of differences in cardiac resynchronization therapy defibrillator effectiveness between men and women in the MADIT-CRT trial.
    Durante A; Cianflone D; Camici PG
    J Am Coll Cardiol; 2011 Jul; 58(4):442-3; author reply 443-4. PubMed ID: 21757127
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.
    Arshad A; Moss AJ; Foster E; Padeletti L; Barsheshet A; Goldenberg I; Greenberg H; Hall WJ; McNitt S; Zareba W; Solomon S; Steinberg JS;
    J Am Coll Cardiol; 2011 Feb; 57(7):813-20. PubMed ID: 21310317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W
    J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and outcome of patients enrolled in US and non-US centres in MADIT-CRT.
    Buber J; Klein H; Moss AJ; McNitt S; Eldar M; Padeletti L; Vogt J; Meine M; Brown MW; Barsheshet A; Zareba W; Goldenberg I
    Eur Heart J; 2011 Nov; 32(21):2697-704. PubMed ID: 21642283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of community wealth on use of cardiac-resynchronization therapy with defibrillators for heart failure patients.
    Farmer SA; Tuohy EJ; Small DS; Wang Y; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):798-807. PubMed ID: 23093561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All cause mortality of cardiac resynchronization therapy with implantable cardioverter defibrillator: a meta-analysis of randomized controlled trials.
    Huang Y; Wu W; Cao Y; Qu N
    Int J Cardiol; 2010 Dec; 145(3):413-7. PubMed ID: 20541819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of defibrillators and resynchronization therapy at the time of evaluation at a heart failure and cardiac transplantation center.
    Sims DB; Garcia LI; Mignatti A; Colombo PC; Jones M; Uriel N; Mancini DM; Jorde UP
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):988-93. PubMed ID: 20353413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interlead difference between T-peak to T-end intervals in resynchronization patients with an implantable cardioverter-defibrillator.
    Suzuki A; Shiga T; Nakai K; Futagawa K; Matsuyama Y; Shoda M; Kasanuki H; Hagiwara N
    J Electrocardiol; 2010; 43(6):706-12. PubMed ID: 20719332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure.
    Zaręba W
    Cardiol J; 2010; 17(6):543-8. PubMed ID: 21154255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter by Varma regarding article, "Predictors of Response to Cardiac Resynchronization Therapy in The Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT)".
    Varma N
    Circulation; 2012 Jun; 125(22):e999; author response e1000. PubMed ID: 22665890
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac resynchronization therapy improves exercise heart rate recovery in patients with heart failure.
    Okutucu S; Aytemir K; Evranos B; Aksoy H; Sabanov C; Karakulak UN; Kaya EB; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Europace; 2011 Apr; 13(4):526-32. PubMed ID: 21076146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging in electrical cardiac devices.
    Willerson JT
    J Am Coll Cardiol; 2011 Feb; 57(7):829-30. PubMed ID: 21310319
    [No Abstract]   [Full Text] [Related]  

  • 14. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy.
    Mooyaart EA; Marsan NA; van Bommel RJ; Thijssen J; Borleffs CJ; Delgado V; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2011 Jul; 108(1):63-8. PubMed ID: 21529733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac resynchronization therapy: current trends and future directions.
    Jacob S; Bharadwaj AS; Panaich SS; Mathew A; Afonso L
    Minerva Cardioangiol; 2010 Dec; 58(6):717-29. PubMed ID: 21135811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.
    Yarnoz MJ; Curtis AB
    Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy.
    Goda A; Lund LH; Mancini D
    J Heart Lung Transplant; 2011 Mar; 30(3):315-25. PubMed ID: 21093299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.